MYGN

Myriad Genetics (MYGN)

About Myriad Genetics (MYGN)

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Details

Daily high

$4.71

Daily low

$4.39

Price at open

$4.41

52 Week High

$8.59

52 Week Low

$3.53

Market cap

425.0M

Dividend yield

0.00%

Volume

830,334

Avg. volume

1.7M

P/E ratio

-1.04

Myriad Genetics News